MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Aziyo Biologics Total Assets 2011-2026 | AZYO
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Aziyo Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.4 M | 36.1 M | 43.4 M | 68.8 M | 67.2 M | 82.8 M | 44.8 M | 47.7 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82.8 M | 36.1 M | 56.7 M |
Quarterly Total Assets Aziyo Biologics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.4 M | 33.8 M | 39.3 M | 48.4 M | 41.9 M | 35.4 M | 54.6 M | 52.3 M | 60.6 M | 68.8 M | 61 M | 52.9 M | 59.9 M | 67.2 M | 59.9 M | 69.7 M | 74.2 M | 82.8 M | 82.8 M | 82.8 M | 82.8 M | 44.8 M | 44.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 82.8 M | 29.4 M | 57.8 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
222 M | $ 32.67 | 5.42 % | $ 1.5 B |  USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.24 | 2.47 % | $ 1.65 B | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.36 | 3.2 % | $ 265 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 38.24 | 4.28 % | $ 5.7 K | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.61 | 0.13 % | $ 122 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 24.41 | 2.89 % | $ 206 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 91.72 | 1.91 % | $ 12.4 B | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.34 | -1.82 % | $ 125 M |  France |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.89 | 3.28 % | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.62 | 3.11 % | $ 741 M | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 178.59 | 7.02 % | $ 13.4 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 87.43 | 2.73 % | $ 3.04 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.18 | 2.63 % | $ 380 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 64.67 | 1.78 % | $ 3.53 B |  Britain |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.67 | 0.71 % | $ 67.8 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
91.7 B | $ 88.04 | 1.87 % | $ 113 B | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.18 | 3.21 % | $ 885 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.68 | -0.3 % | $ 28.5 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.64 | 4.94 % | $ 39.8 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.84 | 1.76 % | $ 352 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.3 | 0.71 % | $ 92.2 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 11.45 | 3.76 % | $ 1.72 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.14 | 10.68 % | $ 19.3 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.46 | 5.56 % | $ 1.13 B | USA |